Latest filing published 19 Jul 2007 for Riot Platforms, Inc., €99k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
1837 RMB Managers L.L.C.: trading record in brief
This profile gathers the share dealings of 1837 RMB Managers L.L.C. in Riot Platforms, Inc. Between 22 September 2006 and 18 July 2007, the trades on record add up to 67 filings.
The open-market side counts 36 purchases for €3.0M alongside 31 sales for €1.0M. Netting one side against the other leaves €2.0M of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2007, the count stands at 34 purchases and 31 sales.
In size, the median ticket on the buying side is €38k.
On 19 July 2007 came the latest disclosure, an open-market sale for €99k in Riot Platforms, Inc. The latest purchase dates back some time: it was published 7,068 days ago, on 3 July 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to 1837 RMB Managers L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,140 shares@ US$5.43AspenBio Pharma, Inc.SEC:0001363399-07-000022:0
- 6,030 shares@ US$5.43AspenBio Pharma, Inc.SEC:0001363399-07-000022:1
- 6,330 shares@ US$5.43AspenBio Pharma, Inc.SEC:0001363399-07-000022:2
- 1,680 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:0
- 400 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:1
- 420 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:2
- 2,382 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:3
- 570 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:4
- 600 shares@ US$5.33AspenBio Pharma, Inc.SEC:0001363399-07-000021:5
- 6,992 shares@ US$4.67AspenBio Pharma, Inc.SEC:0001363399-07-000020:0
- 7,208 shares@ US$4.66AspenBio Pharma, Inc.SEC:0001363399-07-000020:1
- 12,408 shares@ US$4.67AspenBio Pharma, Inc.SEC:0001363399-07-000020:2
- 12,792 shares@ US$4.66AspenBio Pharma, Inc.SEC:0001363399-07-000020:3
- 6,910 shares@ US$4.58AspenBio Pharma, Inc.SEC:0001363399-07-000019:0
- 1,650 shares@ US$4.58AspenBio Pharma, Inc.SEC:0001363399-07-000019:1
- 1,740 shares@ US$4.58AspenBio Pharma, Inc.SEC:0001363399-07-000019:2
- 1,540 shares@ US$4.65AspenBio Pharma, Inc.SEC:0001363399-07-000017:0
- 370 shares@ US$4.65AspenBio Pharma, Inc.SEC:0001363399-07-000017:1
- 390 shares@ US$4.65AspenBio Pharma, Inc.SEC:0001363399-07-000017:2
- 2,700 shares@ US$4.64AspenBio Pharma, Inc.SEC:0001363399-07-000016:0
- 4,800 shares@ US$4.64AspenBio Pharma, Inc.SEC:0001363399-07-000016:1
- 2,140 shares@ US$4.65AspenBio Pharma, Inc.SEC:0001363399-07-000015:0
- 3,812 shares@ US$4.65AspenBio Pharma, Inc.SEC:0001363399-07-000015:1
- 71,200 shares@ US$4.56AspenBio Pharma, Inc.SEC:0001363399-07-000014:0
- 21,500 shares@ US$4.59AspenBio Pharma, Inc.SEC:0001363399-07-000014:1Canonical exit: 30 Sept 2007 (T+90)
25 of 63 declarations
